KORU Medical (NASDAQ: KRMD) CCO reports zero common stock holdings

Rhea-AI Filing Summary

KORU Medical Systems, Inc. filed an initial insider ownership report for its Chief Commercial Officer, Adam R. Kalbermatten. The Form 3 shows that, as of the event date of 07/28/2025, he beneficially owned 0 shares of KORU Medical common stock in direct ownership. This filing establishes his baseline reported ownership as a newly reported officer of the company.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

KALBERMATTEN ADAM R

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NJ 07430

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/28/2025

3. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Power of Attorney filed herewith as Exhibit 24.

	/s/ Thomas Adams Attorney-In-Fact	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the reporting person in the KORU Medical (KRMD) Form 3 filing?

The reporting person is Adam R. Kalbermatten, who serves as Chief Commercial Officer of KORU Medical Systems, Inc.

What does this Form 3 report about Adam R. Kalbermatten's KRMD share ownership?

The Form 3 reports that Adam R. Kalbermatten beneficially owns 0 shares of KORU Medical common stock in direct ownership as of the reported date.

What is the event date shown in this KORU Medical (KRMD) Form 3?

The event date requiring the statement is listed as 07/28/2025.

What is Adam R. Kalbermatten’s relationship to KORU Medical Systems (KRMD)?

He is reported as an officer of KORU Medical Systems, Inc., with the title Chief Commercial Officer, and is not listed as a director or 10% owner.

Does the Form 3 show any indirect ownership or derivative securities for KRMD?

The filing shows 0 shares of common stock directly owned and lists no derivative securities in Table II.